{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:25:27Z","timestamp":1770240327405,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Prostacyclin-associated leg pain is a potentially debilitating adverse effect of prostacyclin therapy for patients with pulmonary arterial hypertension (PAH). However, to our knowledge, this entity has not been systematically studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize the clinical features and metabolic risk factors for prostacyclin-associated leg pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>At one academic medical center, we assembled and analyzed a case series of patients with PAH and prostacyclin-associated leg pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Over a period of 2 years, we identified 11 patients with PAH and prostacyclin-associated leg pain who agreed to participate in this study. Subjects underwent a standardized clinical evaluation, electrodiagnostic assessment, and serologic screen for metabolic causes of peripheral neuropathy. All 11 patients were female; their mean (SD) age was 50 (\u00b19) years; their median (interquartile range) PAH duration was 56 (20\u201396) months; and their prostacyclin therapy duration was a median (interquartile range) of 20 (14\u201336) months. All patients reported leg pain beginning soon after prostacyclin initiation and varying with dose. All described a neuropathic pain in a symmetric, distal, stocking distribution. Neurologic examination revealed a sensory, small-fiber, predominantly peripheral neuropathy in seven (78%) patients. Results of autonomic reflex testing and thermoregulatory sweat testing were abnormal in 82% and 90% of patients, respectively, suggesting small-fiber neuropathy. Serologic evaluation identified a new, previously unrecognized contributor to neuropathy in eight (73%) patients, including vitamin B12 deficiency in six (55%), uncompensated hypothyroidism in three (27%), and diabetes mellitus in one (9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chronic prostacyclin-associated leg pain is associated with a small-fiber neuropathy. Treatable metabolic contributors (vitamin B12 deficiency, thyroid dysfunction, or diabetes) appear to be common possible \u201csecond hits\u201d that may be underrecognized. We recommend screening for possible metabolic contributors in patients who have otherwise unexplained leg pain in the setting of PAH and current or anticipated prostacyclin therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201609-674oc","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T17:24:47Z","timestamp":1657646687000},"page":"206-212","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of Prostacyclin-associated Leg Pain in Patients with Pulmonary Arterial Hypertension"],"prefix":"10.1093","volume":"14","author":[{"given":"Gabriel L.","family":"Pagani-Est\u00e9vez","sequence":"first","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M.","family":"Swetz","sequence":"additional","affiliation":[{"name":"Center for Palliative and Supportive Care, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama; and"},{"name":"Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"McGoon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Frantz","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"Tointon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Karnyski","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise A.","family":"Durst","sequence":"additional","affiliation":[{"name":"Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-8588","authenticated-orcid":false,"given":"James C.","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Neurology"},{"name":"Pain Division, Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"issue":"25","key":"2026020402583023000_bib1","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026020402583023000_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"2026020402583023000_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"2026020402583023000_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"2026020402583023000_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.healun.2012.08.010","article-title":"Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey","volume":"31","author":"Swetz","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2026020402583023000_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpainsymman.2015.07.012","article-title":"Symptom interference severity and health-related quality of life in pulmonary arterial hypertension","volume":"51","author":"Matura","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"2026020402583023000_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/677365","article-title":"Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey","volume":"4","author":"Fenstad","year":"2014","journal-title":"Pulm Circ"},{"key":"2026020402583023000_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.89.4.497","article-title":"Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension","volume":"89","author":"Barst","year":"1986","journal-title":"Chest"},{"key":"2026020402583023000_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"2026020402583023000_bib10","volume-title":"Pulmonary hypertension: a patient\u2019s survival guide.","author":"Hayes","year":"2013","edition":"5th ed"},{"key":"2026020402583023000_bib11","first-page":"CD002994","article-title":"Prostacyclin for pulmonary hypertension in adults","volume":"2","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2026020402583023000_bib12","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jacc.2004.02.036","article-title":"Prostanoid therapy for pulmonary arterial hypertension","volume":"43","author":"Badesch","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026020402583023000_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026020402583023000_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1164\/rccm.200204-333OC","article-title":"Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol","volume":"167","author":"Kuhn","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402583023000_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780195385113.001.0001","volume-title":"Clinical neurophysiology.","author":"Daube","year":"2009","edition":"3rd ed."},{"key":"2026020402583023000_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mus.21227","article-title":"Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review)","volume":"39","author":"England","year":"2009","journal-title":"Muscle Nerve"},{"key":"2026020402583023000_bib17","first-page":"23","article-title":"Double crush syndrome: what is the evidence?","volume":"1","author":"Swenson","year":"1993","journal-title":"JNMS J Neuromusculoskelet Syst"},{"key":"2026020402583023000_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/AAP.0000000000000185","article-title":"Neurologic evaluation and management of perioperative nerve injury","volume":"40","author":"Watson","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"2026020402583023000_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.mayocp.2015.05.004","article-title":"Peripheral neuropathy: a practical approach to diagnosis and symptom management","volume":"90","author":"Watson","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"2026020402583023000_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjmed.2003.09.040","article-title":"Hypothyroidism and pulmonary arterial hypertension","volume":"116","author":"Ghamra","year":"2004","journal-title":"Am J Med"},{"key":"2026020402583023000_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1378\/chest.122.5.1668","article-title":"High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension","volume":"122","author":"Chu","year":"2002","journal-title":"Chest"},{"key":"2026020402583023000_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.21226","article-title":"Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review)","volume":"39","author":"England","year":"2009","journal-title":"Muscle Nerve"},{"key":"2026020402583023000_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1124\/jpet.106.110387","article-title":"Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis","volume":"319","author":"Pulichino","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020402583023000_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","article-title":"Altered pain perception and inflammatory response in mice lacking prostacyclin receptor","volume":"388","author":"Murata","year":"1997","journal-title":"Nature"},{"key":"2026020402583023000_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1468-2982.2009.01923.x","article-title":"Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs","volume":"30","author":"Wienecke","year":"2010","journal-title":"Cephalalgia"},{"key":"2026020402583023000_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pain.2008.03.018","article-title":"Prostacyclin (epoprostenol) induces headache in healthy subjects","volume":"139","author":"Wienecke","year":"2008","journal-title":"Pain"},{"key":"2026020402583023000_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2011.00024","article-title":"Prostacyclin: an inflammatory paradox","volume":"2","author":"Stitham","year":"2011","journal-title":"Front Pharmacol"},{"key":"2026020402583023000_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1183\/09031936.00145708","article-title":"Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension","volume":"34","author":"Wensel","year":"2009","journal-title":"Eur Respir J"},{"key":"2026020402583023000_bib29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cardfail.2009.06.001","article-title":"Impairment of autonomic nervous system activity in patients with pulmonary arterial hypertension: a case control study","volume":"15","author":"Dimopoulos","year":"2009","journal-title":"J Card Fail"},{"key":"2026020402583023000_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3349\/ymj.2010.51.1.82","article-title":"Effect of sildenafil on neuropathic pain and hemodynamics in rats","volume":"51","author":"Huang","year":"2010","journal-title":"Yonsei Med J"},{"key":"2026020402583023000_bib31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/2\/206\/66714341\/annalsats_14_2_206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/2\/206\/66714341\/annalsats_14_2_206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:58:45Z","timestamp":1770191925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/14\/2\/206\/8453525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,1]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201609-674oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2]]},"published":{"date-parts":[[2017,2,1]]}}}